193 related articles for article (PubMed ID: 27521448)
1. Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain Metastases.
Osswald M; Blaes J; Liao Y; Solecki G; Gömmel M; Berghoff AS; Salphati L; Wallin JJ; Phillips HS; Wick W; Winkler F
Clin Cancer Res; 2016 Dec; 22(24):6078-6087. PubMed ID: 27521448
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
3. VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.
García-Martín AB; Zwicky P; Gruber T; Matti C; Moalli F; Stein JV; Francisco D; Enzmann G; Levesque MP; Hewer E; Lyck R
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1995-2010. PubMed ID: 29762071
[TBL] [Abstract][Full Text] [Related]
4. Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
Zhang RD; Price JE; Fujimaki T; Bucana CD; Fidler IJ
Am J Pathol; 1992 Nov; 141(5):1115-24. PubMed ID: 1443046
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.
Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B
Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829
[TBL] [Abstract][Full Text] [Related]
6. Therapeutics for Brain Metastases, v3.
Steeg PS; Zimmer A; Gril B
Clin Cancer Res; 2016 Dec; 22(24):5953-5955. PubMed ID: 27803066
[TBL] [Abstract][Full Text] [Related]
7. The role of the organ microenvironment in brain metastasis.
Fidler IJ
Semin Cancer Biol; 2011 Apr; 21(2):107-12. PubMed ID: 21167939
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and vascular integrity of breast cancer brain metastasis.
Lu W; Bucana CD; Schroit AJ
Int J Cancer; 2007 Mar; 120(5):1023-6. PubMed ID: 17187362
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
10. Targeting the PI3K pathway in the brain--efficacy of a PI3K inhibitor optimized to cross the blood-brain barrier.
Salphati L; Heffron TP; Alicke B; Nishimura M; Barck K; Carano RA; Cheong J; Edgar KA; Greve J; Kharbanda S; Koeppen H; Lau S; Lee LB; Pang J; Plise EG; Pokorny JL; Reslan HB; Sarkaria JN; Wallin JJ; Zhang X; Gould SE; Olivero AG; Phillips HS
Clin Cancer Res; 2012 Nov; 18(22):6239-48. PubMed ID: 22992516
[TBL] [Abstract][Full Text] [Related]
11. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
Yan H; Wang L; Wang J; Weng X; Lei H; Wang X; Jiang L; Zhu J; Lu W; Wei X; Li C
ACS Nano; 2012 Jan; 6(1):410-20. PubMed ID: 22148835
[TBL] [Abstract][Full Text] [Related]
12. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
13. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
[TBL] [Abstract][Full Text] [Related]
14. Tesmilifene modifies brain endothelial functions and opens the blood-brain/blood-glioma barrier.
Walter FR; Veszelka S; Pásztói M; Péterfi ZA; Tóth A; Rákhely G; Cervenak L; Ábrahám CS; Deli MA
J Neurochem; 2015 Sep; 134(6):1040-54. PubMed ID: 26112237
[TBL] [Abstract][Full Text] [Related]
15. In-vivo longitudinal MRI study: an assessment of melanoma brain metastases in a clinically relevant mouse model.
Henry MN; Chen Y; McFadden CD; Simedrea FC; Foster PJ
Melanoma Res; 2015 Apr; 25(2):127-37. PubMed ID: 25513779
[TBL] [Abstract][Full Text] [Related]
16. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase.
Kaya M; Ahishali B
Methods Mol Biol; 2011; 763():369-82. PubMed ID: 21874465
[TBL] [Abstract][Full Text] [Related]
17. Quantification of blood-brain barrier solute permeability and brain transport by multiphoton microscopy.
Shi L; Zeng M; Sun Y; Fu BM
J Biomech Eng; 2014 Mar; 136(3):031005. PubMed ID: 24193698
[TBL] [Abstract][Full Text] [Related]
18. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
Murrell J; Board R
Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study.
van Vliet EA; Otte WM; Gorter JA; Dijkhuizen RM; Wadman WJ
Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435
[TBL] [Abstract][Full Text] [Related]
20. The biology of melanoma brain metastasis.
Fidler IJ; Schackert G; Zhang RD; Radinsky R; Fujimaki T
Cancer Metastasis Rev; 1999; 18(3):387-400. PubMed ID: 10721492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
